KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Invested Capital (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Invested Capital readings, the most recent being $508.6 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 28.97% to $508.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $508.6 million, a 28.97% decrease, with the full-year FY2025 number at $508.6 million, down 28.97% from a year prior.
  • Invested Capital hit $508.6 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $559.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.7 billion in Q4 2022 to a low of $356.4 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $1.0 billion (2023), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Invested Capital: soared 341.13% in 2022 and later plummeted 44.59% in 2024.
  • Ginkgo Bioworks Holdings' Invested Capital stood at $1.6 billion in 2021, then increased by 10.95% to $1.7 billion in 2022, then crashed by 36.91% to $1.1 billion in 2023, then plummeted by 34.73% to $716.1 million in 2024, then fell by 28.97% to $508.6 million in 2025.
  • The last three reported values for Invested Capital were $508.6 million (Q4 2025), $559.8 million (Q3 2025), and $613.0 million (Q2 2025) per Business Quant data.